Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.06 USD | -3.29% | -2.83% | -30.17% |
May. 09 | BioXcel Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 09 | Transcript : BioXcel Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 3.36M | Sales 2025 * | 9.16M | Capitalization | 77.31M |
---|---|---|---|---|---|
Net income 2024 * | -99M | Net income 2025 * | -83M | EV / Sales 2024 * | 60.3 x |
Net Debt 2024 * | 125M | Net Debt 2025 * | 115M | EV / Sales 2025 * | 21 x |
P/E ratio 2024 * |
-0.79
x | P/E ratio 2025 * |
-1.18
x | Employees | 74 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.93% |
Latest transcript on BioXcel Therapeutics, Inc.
1 day | -3.29% | ||
1 week | -2.83% | ||
Current month | -18.25% | ||
1 month | -25.09% | ||
3 months | -42.62% | ||
6 months | -53.18% | ||
Current year | -30.17% |
Managers | Title | Age | Since |
---|---|---|---|
Vimal Mehta
FOU | Founder | 63 | 17-03-28 |
Director of Finance/CFO | 66 | 17-09-30 | |
Frank Yocca
CTO | Chief Tech/Sci/R&D Officer | 68 | 17-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 22-06-30 |
Peter Mueller
CHM | Chairman | 68 | 17-03-31 |
Sandeep Laumas
BRD | Director/Board Member | 56 | 17-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 9 M€ | +11.16% | - | |
0.00% | 1,487 M€ | +8.31% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 2.06 | -3.29% | 730,879 |
24-05-14 | 2.13 | -2.52% | 468,083 |
24-05-13 | 2.185 | +4.55% | 463,158 |
24-05-10 | 2.09 | -9.33% | 696,007 |
24-05-09 | 2.305 | +8.73% | 665,423 |
Delayed Quote Nasdaq, May 15, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.17% | 79.94M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- BTAI Stock